KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Long-Term Investments (2016 - 2024)

Supernus Pharmaceuticals (SUPN) has disclosed Long-Term Investments for 13 consecutive years, with $11.7 million as the latest value for Q1 2024.

  • On a quarterly basis, Long-Term Investments fell 78.47% to $11.7 million in Q1 2024 year-over-year; TTM through Mar 2024 was $11.7 million, a 78.47% decrease, with the full-year FY2023 number at $16.6 million, down 82.3% from a year prior.
  • Long-Term Investments was $11.7 million for Q1 2024 at Supernus Pharmaceuticals, down from $16.6 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $534.7 million in Q1 2020 to a low of $11.7 million in Q1 2024.
  • A 5-year average of $215.4 million and a median of $131.9 million in 2022 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: grew 24.2% in 2021, then plummeted 82.3% in 2023.
  • Supernus Pharmaceuticals' Long-Term Investments stood at $350.4 million in 2020, then tumbled by 65.99% to $119.2 million in 2021, then fell by 21.21% to $93.9 million in 2022, then tumbled by 82.3% to $16.6 million in 2023, then fell by 29.82% to $11.7 million in 2024.
  • Per Business Quant, the three most recent readings for SUPN's Long-Term Investments are $11.7 million (Q1 2024), $16.6 million (Q4 2023), and $25.1 million (Q3 2023).